Form 8-K - Current report:
SEC Accession No. 0000945439-00-000002
Filing Date
2000-04-13
Accepted
2000-04-13 00:00:00
Documents
2
Period of Report
2000-04-10
Items
Item 4: Changes in registrant's certifying accountant
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ITEM 4. CHG ACCT. & ACCT. LETTER 8-K 3434
2 EX-16 1156
  Complete submission text file 0000945439-00-000002.txt   6153
Mailing Address 750 LEXINGTON AVENUE SUITE 2750 NEW YORK NY 10022-1282
Business Address 750 LEXINGTON AVE NEW YORK NY 10022 2123558484
EMBRYO DEVELOPMENT CORP (Filer) CIK: 0000945439 (see all company filings)

EIN.: 133832099 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 000-27028 | Film No.: 599863
SIC: 3845 Electromedical & Electrotherapeutic Apparatus